Margin of Insight
← Free primer

Investment Memorandum · Preview

For informational purposes only. Not investment advice.

The Coca-Cola Company

KO

NEUTRAL

May 23, 2026

Research Conclusion

The Coca-Cola Company is a Wide-Moat, Stable-Trend Consumer Staples compounder trading approximately at intrinsic value at $81.48. Probability-weighted fair value is $82 per share (range $73–$92). The risk/reward at current levels is symmetric — Bull $96 (+18%) vs. Bear $65 (−20%). KO is a portfolio stabilizer with a 63-year dividend streak and one of the most durable competitive moats in global consumer goods. The expected total return at base case is ~7–8%/yr (5–6% EPS growth + 2.6% dividend + slight multiple compression headwind). We recommend HOLD on existing positions and patient accumulation only on pullbacks to the $65–72 zone where margin of safety re-emerges.

Company Overview & Moat Assessment

The Coca-Cola Company (KO, NYSE) is the world's largest non-alcoholic beverage company by brand value, operating an asset-light franchise model in 200+ countries. KO sells branded concentrate (~59% of revenue) and finished products (~41%) to ~225 independent bottlers that operate ~900 plants and reach 30M+ retail outlets globally. The portfolio spans Coca-Cola, Diet Coke, Coca-Cola Zero Sugar (18 consecutive quarters of value share gains), Sprite, Fanta, Powerade, BodyArmor, fairlife, smartwater, Topo Chico, Costa Coffee, plus a 19.4% stake in Monster Beverage. FY2025 revenue was $47.9B, comparable EPS $3.00, adjusted FCF $11.4B, and comparable operating margin 31.2%. Henrique Braun became CEO on April 1, 2026, with James Quincey remaining as Executive Chairman. Berkshire Hathaway owns 9.52% (~$31.3B). Market cap: $351B; forward P/E ~24.5x on FY2026E EPS $3.32.

▲ Bull Case

  • ◆Organic acceleration beats conservative guidance — KO has historically guided low and delivered high (FY2024: guided +7–8%, delivered +12%). FY2026 guidance of +4–5% organic looks conservative against Q1's +10% start. If Q2–Q4 average +6–7% organic with FIFA tailwind, comp. EPS reaches $3.35–3.45 vs. guided $3.27, with re-rating to 25–27x P/E. Bull-case fair value: $96.
  • ◆fairlife + Zero Sugar drive structural margin and category lift — fairlife is on a >2pp North American organic growth contribution path, supported by 25%+ supply expansion. Zero Sugar is gaining global volume share with the GLP-1 user base as a tailwind. Together these two platforms offset GLP-1 headwinds in sparkling and produce mix-based margin expansion to 33%+.
  • ◆Defensive re-rating in macro stress — KO's beta of ~0.55 and Dividend King status make it a destination for rotational flows in equity drawdowns. Historically, KO re-rates to 26–28x P/E in risk-off environments. In a recession, KO could see multiple expansion of 2–4 turns without earnings growth, delivering +10–15% capital appreciation.

▼ Bear Case

  • ◆GLP-1 hits the structural break threshold — If GLP-1 household penetration reaches 35% by 2030 (vs. 23% today) and Zero Sugar substitution proves incomplete, full-sugar CSD volume could decline 1.5–2.5% annually. Total organic growth compresses to 2–3% by FY2028–2030, incompatible with a 24x forward P/E. Market re-rates to 20–22x. Bear-case fair value: $65.
  • ◆IRS adverse ruling crystallizes — KO has deposited $6.1B with the IRS pending Tax Court resolution. Maximum exposure is $12B+ across all open years (2007–2013+). An adverse ruling at full scale forces another $6B+ cash outflow, depressing GAAP EPS by ~$1.50/share one-time. Sentiment hit could be 2–4 turns of multiple compression. Combined with GLP-1 bear case = Severe scenario at $52.
  • ◆Multiple compression on dividend math — At 24x forward P/E and 2.6% yield, KO requires 5–6%/yr EPS growth to deliver 8% total returns. If organic growth compresses to 3–4%, EPS growth falls to 4–5%, and total return profile compresses to ~6–7%/yr. The defensive premium evaporates and KO trades closer to KDP's 14x P/E. Risk: ~$15/share of compression from multiple alone.
Primary Debate on Wall Street

“The Street consensus is constructive but unconvicted: ~65% Buy/Strong Buy, 12-month price targets $80–$92, BofA at $90. The bullish argument centers on the asset-light moat + dividend reliability + emerging-market runway; the bearish argument centers on the defensive premium already being priced. The principal divergence is between bulls who model fairlife + EM volume + Costa RTD scaling as offsetting all bear overhangs vs. bears who model the IRS hit + sustained FX + GLP-1 as compressing total returns to high-single-digits. Neither side has won the debate — the stock trades range-bound around fair value because Berkshire's permanent 9.52% stake creates structural demand floor and passive index ownership dominates active flows. The debate will be resolved by data — specifically, Q2 2026 organic growth, IRS ruling timing, and GLP-1 quarterly trend.”

Top Catalysts
  • ◆Q2 2026 earnings — FIFA volume tailwind (Aug 2026, High probability)
  • ◆FY2026 organic beat vs. +4–5% guidance (Feb 2027, Medium-High probability)
  • ◆IRS Tax Court ruling (2026–2028, Low-Medium probability)
  • ◆Braun first major strategic announcement (H2 2026, Medium probability)
  • ◆fairlife capacity expansion completion → revenue inflection (H2 2026–2027, Medium-High probability)
  • ◆Zero Sugar volume share prints (quarterly Nielsen/IRI data, High probability)
  • ◆BodyArmor share gains vs. Gatorade (2026–2027, Low-Medium probability)
Top Risks
  • ◆FX structural headwind (60% non-USD revenue) — High severity, High (structural) probability
  • ◆GLP-1 secular demand shift (35% household penetration by 2030) — Medium-High severity, Medium probability
  • ◆IRS Tax Court adverse ruling (up to $12B+ liability) — Medium-High severity, Low-Medium probability
  • ◆Sugar tax + plastic packaging regulation escalation — Medium severity, Low-Medium probability
  • ◆BodyArmor additional impairment / continued underperformance — Medium severity, Medium probability
  • ◆EM political/economic instability (Nigeria, Argentina, Turkey) — Low-Medium severity, Medium probability
  • ◆MNST distribution dependency / Celsius gaining share — Low-Medium severity, Low probability
  • ◆Braun strategic pivot (CEO transition risk) — Low-Medium severity, Medium probability

Full Memo Continues

5 more sections, locked

  • ●
    Valuation Range & DCF
    Base/bull/bear fair-value range, WACC, terminal growth, sensitivity to revenue + margin assumptions.
  • ●
    Risk/Reward Assessment
    Position-sizing framework with explicit upside/downside skew and entry conditions.
  • ●
    Management & Capital Allocation
    Multi-year capital-allocation track record, incentive alignment, and management readout.
  • ●
    Monitoring Framework
    What to watch each quarter — leading indicators and inflection signals tracked by the analyst.
  • ●
    Unresolved Questions
    Open analyst questions and follow-up research items — the depth signal.

For Agents — $2 per memo

Call the JSON API with a Stripe Shared Payment Token. No account, no signup — just pay and call.

GET /api/v1/research/KO/memo
Authorization: Bearer spt_...

Fund managers — coverage subscriptions launching soon. See marginofinsight.com.

Margin of Insight

For informational purposes only. Not investment advice.